Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment

S Prange, H Klinger, C Laurencin, T Danaila… - Drugs & Aging, 2022 - Springer
Depression is one of the most frequent and burdensome non-motor symptoms in
Parkinson's disease (PD), across all stages. Even when its severity is mild, PD depression …

Advances in Parkinson's disease detection and assessment using voice and speech: A review of the articulatory and phonatory aspects

L Moro-Velazquez, JA Gomez-Garcia… - … Signal Processing and …, 2021 - Elsevier
Parkinson's Disease (PD) affects speech in the form of dysphonia and hypokinetic
dysarthria. Multiple studies have evaluated PD's influence on different aspects of speech …

Biomarkers for closed-loop deep brain stimulation in Parkinson disease and beyond

W Bouthour, P Mégevand, J Donoghue… - Nature Reviews …, 2019 - nature.com
Subthalamic deep brain stimulation (DBS) for Parkinson disease (PD) currently requires
laborious open-loop programming, which can mitigate the benefits of this treatment …

[PDF][PDF] Doença de Parkinson: Revisão clínica e atualização [Parkinson's disease: Clinical review and update]

V Cabreira, J Massano - Acta Med Port, 2019 - academia.edu
RESUMO A doença de Parkinson é a segunda doença neurodegenerativa mais comum,
tendo sido documentado um aumento significativo da sua prevalência nas últimas três …

A cortical pathogenic theory of Parkinson's disease

G Foffani, JA Obeso - Neuron, 2018 - cell.com
In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic
neurons in the substantia nigra pars compacta (SNc) is associated with classic motor …

The spectrum of “off” in Parkinson's disease: what have we learned over 40 years?

KL Chou, M Stacy, T Simuni, J Miyasaki… - Parkinsonism & Related …, 2018 - Elsevier
The terms “on” and “off” were used by Marsden and his contemporaries over 40 years ago to
describe times when Parkinson's disease patients experienced good motor function (“on”) …

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications …

E Lhommée, L Wojtecki, V Czernecki, K Witt… - The Lancet …, 2018 - thelancet.com
Background Although subthalamic stimulation is a recognised treatment for motor
complications in Parkinson's disease, reports on behavioural outcomes are controversial …

Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease

MA Cenci, K Skovgård, P Odin - Neuropharmacology, 2022 - Elsevier
Dopamine replacement therapy with l-DOPA is the most efficacious symptomatic treatment
for Parkinson's disease, but its utility is limited by a development of motor fluctuations and …

Prevalence of non‐motor symptoms and non‐motor fluctuations in Parkinson's disease using the MDS‐NMS

C Rodriguez‐Blazquez, A Schrag… - Movement Disorders …, 2021 - Wiley Online Library
Background Non‐motor symptoms (NMS) are frequent in Parkinson's disease (PD).
Objectives To estimate the prevalence of NMS and of non‐motor fluctuations (NMF) using …

Doença de Parkinson: Revisão clínica e atualização

V Cabreira, J Massano - Acta Médica Portuguesa, 2019 - actamedicaportuguesa.com
Parkinson's disease is the second most common neurodegenerative disorder, and a
significant increase in its prevalence in the past three decades has been documented …